Abstract
Osteoporosis is a common systemic skeletal disorder resulting in bone fragility and increased fracture risk. Evidence-based screening strategies improve identification of patients who are most likely to benefit from drug treatment to prevent fracture. In addition, careful consideration of when pharmacotherapy should be started, choice of medication, and duration of treatment maximizes the benefits of fracture prevention while minimizing potential harms of long-term drug exposure.
Citation impact
162
total citations
- FWCI
- 70.09
- Percentile
- 100%
- References
- 56
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Medicine
- Osteoporosis
- Pharmacotherapy
- Fragility fracture
- Intensive care medicine
- Internal medicine
- Bone mineral
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.